NYSE: RCUS - Arcus Biosciences, Inc.

Yield per half year: -45.42%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Arcus Biosciences, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About Arcus Biosciences, Inc.

Arcus Biosciences, Inc., биофармацевтическая компания, работающая на клинической стадии, занимается разработкой и коммерциализацией методов лечения рака в Соединенных Штатах. Ассортимент продукции компании включает AB928, двойной антагонист аденозиновых рецепторов A2aA2b, который проходит фазу 1b2 клинических испытаний; и Зимберелимаб, моноклональное антитело против PD-1, которое проходит фазу Ib клинических испытаний для монотерапии.

more details
Он также разрабатывает AB154, моноклональное антитело против TIGIT, которое находится в фазе 2 разработки для лечения метастатического немелкоклеточного рака легкого первой линии в комбинации с зимберелимабом и AB928; и AB680, низкомолекулярный ингибитор CD73, находится в фазе 11b исследования для лечения метастатического рака поджелудочной железы первой линии. Arcus Biosciences, Inc. заключила соглашение о сотрудничестве в области клинической разработки со Strata Oncology, Inc. для оценки Зимберелимаба; и лицензионные соглашения с Taiho Pharmaceutical Co., Ltd, Abmuno Therapeutics LLC и WuXi Biologics (Cayman) Inc. Компания была основана в 2015 году и базируется в Хейворде, Калифорния.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2018-03-15
ISIN US03969F1093
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Сайт http://www.arcusbio.com
Цена ао 8.4
Change price per day: 0% (8.4)
Change price per week: -7.59% (9.09)
Change price per month: -17.32% (10.16)
Change price per 3 month: -47.2% (15.91)
Change price per half year: -45.42% (15.39)
Change price per year: -49.55% (16.65)
Change price per 3 year: -77.74% (37.73)
Change price per 5 year: -39.87% (13.97)
Change price per year to date: -43.66% (14.91)
All parameters

Underestimation

Title Value Grade
P/S 11.48 1
P/BV 2.91 6
P/E 15.42 7
EV/EBITDA -4.22 0
Total: 5.38

Efficiency

Title Value Grade
ROA, % -28.04 0
ROE, % -66.45 0
Total: 0.3333

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0.2243

Debt

Title Value Grade
Debt/EBITDA -0.0378 10
Total: 10

Growth impulse

Title Value Grade
Yield Revenue, % 680 10
Yield Ebitda, % 219.05 10
Yield EPS, % 135.72 10
Total: 10
More

Institutions Volume Share, %
Blackrock Inc. 10035170 11.04
FMR, LLC 4728782 5.2
Vanguard Group Inc 4680716 5.15
State Street Corporation 4239577 4.67
Octagon Capital Advisors LP 1868000 2.06
Ameriprise Financial, Inc. 1634805 1.8
Invus Financial Advisors, LLC 1612077 1.77
Boxer Capital, LLC 1602200 1.76
Dimensional Fund Advisors LP 1594609 1.75
AllianceBernstein L.P. 1185944 1.31

ETFShare, %Profitability for 1 year, %Dividends, %
Range Cancer Therapeutics ETF 1.23035 47.24 0.11955
Virtus LifeSci Biotech Clinical Trials ETF 0.76808 63.04 0.33
Invesco S&P SmallCap Health Care ETF 0.64942 10.25 0.41696
First Trust Innovation Leaders ETF 0.50718 45.14 0.51521
Syntax Stratified SmallCap ETF 0.14556 13.51 1.639
Direxion Daily S&P Biotech Bull 3x Shares 0.13311 4067.92 0.25924
SPDR S&P SmallCap 600 ESG ETF 0.10491 18.95 1.85316
Avantis U.S Small Cap Equity ETF 0.08667 27.77 1.68271
SPDR S&P 600 Small Cap Value ETF 0.08162 11.01 2.34209
Vanguard S&P Small-Cap 600 Value ETF 0.08 12.06 2.40883
Vanguard Russell 2000 Growth ETF 0.07 23.05 0.60264
Vanguard S&P Small-Cap 600 ETF 0.07 13.46 1.89226
SPDR Portfolio S&P 600 Small Cap ETF 0.06937 13.05 1.84119
iShares Russell 2000 Growth ETF 0.06617 38.04 0.6026
Vanguard S&P Small-Cap 600 Growth ETF 0.06 30.31 1.37064
SPDR S&P 600 Small Cap Growth ETF 0.05894 14.13 1.33495
JPMorgan BetaBuilders U.S. Small Cap Equity Fund 0.05678 24.75 1.59225
Nuveen ESG Small-Cap ETF 0.0523 13.91 1.41019
ProShares Ultra SmallCap600 0.04886 49.8 1.83727
iShares ESG Aware MSCI USA Small-Cap ETF 0.045 18.09 1.49366
Vanguard Russell 2000 ETF 0.03 17.16 1.48801
Schwab U.S. Small-Cap ETF 0.02468 17.47 1.51433
Invesco FTSE RAFI US 1500 Small-Mid ETF 0.02267 17.58 1.75869
iShares Morningstar Small-Cap Growth ETF 0.02041 33.63 0.72598
iShares Morningstar Small-Cap Growth ETF 0.02041 587.89 0.72598
ProShares UltraPro Russell2000 0.01937 89.82 1.47873
iShares Morningstar Small-Cap ETF 0.01843 30.1 1.60498
iShares Morningstar Small-Cap ETF 0.01843 391.25 1.60498
iShares Morningstar Small Cap Value ETF 0.01642 26.7 2.50476
iShares Morningstar Small-Cap Value ETF 0.01642 201.65 2.50476
Invesco S&P SmallCap 600 Revenue ETF 0.01521 30.92 1.94562
iShares U.S. Tech Breakthrough Multisector ETF 0.01435 21.8 0.73986
Fidelity MSCI Health Care Index ETF 0.01307 3 1.46057
Dimensional U.S. Core Equity 2 ETF 0.00798 30.76 1.47098
SPDR Portfolio MSCI Global Stock Market ETF 0.00775 17.99 2.19607
FlexShares Morningstar US Market Factor Tilt Index Fund 0.00601 21.94 1.69572
ProShares Hedge Replication ETF 0.00548 5.92 1.47892
Humankind US Stock ETF 0.00495 18.81 1.99919
SPDR S&P 1500 Value Tilt ETF 0.00374 27.15 2.3833
Avantis U.S. Equity ETF 0.00372 23.04 1.59151
Dimensional US Core Equity Market ETF 0.00355 30.98 1.40618
Schwab U.S. Broad Market ETF 0.00159 24.86 1.43354
Dimensional U.S. Equity ETF 0.00155 31.53 1.3557
SPDR Portfolio S&P 1500 Composite Stock Market ETF 0.00152 24.29 1.46083
iShares Russell 3000 ETF 0.00135 24.83 1.43482
Dimensional US Marketwide Value ETF 0.0007 24.88 2.11042
SPDR S&P 1500 Momentum Tilt ETF 0.00007 38.25 1.12176
Vanguard Russell 3000 ETF 0 31.87 1.43817
Vanguard ESG U.S. Stock ETF 0 23.54 1.26927
0.1131.121.46



Head Job title Payment Year of birth
Dr. Terry J. Rosen Ph.D. Co-Founder, Chairman & CEO 756.11k 1960 (65 years)
Mr. Robert C. Goeltz II Principal Financial Officer & CFO 745.29k 1973 (52 years)
Dr. Juan Carlos Jaen Ph.D. Co- Founder & President 931.14k 1958 (67 years)
Dr. Jonathan Yingling Ph.D. Chief Scientific Officer N/A 1969 (56 years)
Ms. Jennifer A. Jarrett M.B.A. Chief Operating Officer 925.29k 1971 (54 years)
Mr. Alexander Azoy VP of Finance & Principal Accounting Officer N/A 1976 (49 years)
Dr. Dimitry S.A. Nuyten M.D., Ph.D. Chief Medical Officer 700.34k 1976 (49 years)
Dr. K. Christopher Garcia Ph.D. Co-Founder & Member of Scientific Advisory Board N/A
Ms. Carolyn C. Tang J.D. General Counsel & Corporate Secretary 1979 (46 years)
Holli Kolkey Vice President of Corporate Communications

Address: United States, Hayward, CA , 3928 Point Eden Way - open in Google maps, open in Yandex maps
Website: http://www.arcusbio.com